241710 — Cosmecca Korea Co Balance Sheet
0.000.00%
- KR₩461bn
- KR₩609bn
- KR₩524bn
- 81
- 45
- 36
- 56
Annual balance sheet for Cosmecca Korea Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 31,786 | 30,097 | 26,368 | 39,441 | 64,440 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 54,204 | 82,038 | 86,075 | 113,811 | 119,377 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 149,800 | 183,262 | 186,758 | 221,214 | 255,493 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 156,231 | 155,025 | 155,006 | 159,098 | 207,197 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 358,963 | 391,569 | 392,756 | 432,626 | 517,950 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 141,437 | 135,407 | 142,989 | 154,577 | 170,560 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 229,205 | 249,320 | 246,102 | 263,092 | 299,539 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 129,759 | 142,250 | 146,654 | 169,533 | 218,411 |
Total Liabilities & Shareholders' Equity | 358,963 | 391,569 | 392,756 | 432,626 | 517,950 |
Total Common Shares Outstanding |